The latest Houston cohort for gBETA has been announced. Photo courtesy of gBETA

The sixth Houston cohort for global startup accelerator and investor gener8tor's gBETA program is underway, and five Houston early-stage companies have joined the program.

The no-equity program, which is based out of the Downtown Launchpad, kicked off in September and lasts seven weeks. In that time, the startups are connected to a national network of mentors, customers, corporate partners, and investors.

“This gener8tor Houston cohort is among our strongest yet,” says Robert Pieroni, director of Economic Development at Central Houston Inc., in the news release. “We are excited about the caliber of entrepreneurs the Downtown Launchpad is attracting and the entrepreneurial ecosystem being created.”

The program concludes at a public showcase event at 5 pm on November 17 at Amegy Bank Courtyard.

“I’m thrilled about this cohort,” says Muriel Foster, gBETA Houston director, in the release. “We’ve seen the incredible economic impact of the gBETA program in other parts of the country, and we’re excited to bring that same impact to Houston.”

Here are the members of gBETA Houston's latest cohort:

CultureLancer

CultureLancer's all-in-one career-focused platform connects students at HBCUs with opportunities to gain industry-specific education and experience. CultureLancer also provides companies with the ability to source qualified diverse talent to meet their needs. CultureLancer has onboarded 30 students with each completing certification in digital marketing, closing on two contracts, and currently onboarding companies for beta testing.

EYF

EYF gamifies financial literacy education and provides children with a fun alternative to educational programming. EYF aims to teach financial literacy and economics in a fun, interactive, and applicable way. EYF is set to go to market at the end of of the year.

Oodles

Oodles automates the sales process and 24/7 customer service for e-commerce retailers through a conversational AI chatbot. Leveraging AI and machine learning, Oodles chatbot results in significant cost savings for retailers and improves customer retention and loyalty. Oodles has currently raised a seed round of $280,000, launched the product, and onboarded 10 customers.

SafetyKay

SafetyKay LLC promotes safety awareness to young children. SafetyKay focuses on decreasing fatality and accident rates among children ages 5-12 years by teaching them critical health and safety skills. SafetyKay's current safety awareness material has been viewed 81,359 times and it is currently in the process of transitioning into a mobile app platform.

Stobridge Education Inc.

Stobridge Education Inc. connects students with mentors and postsecondary education college, career and life resources for better outcomes. Through its comprehensive and fully integrated web and mobile platform, Stobridge Education is a safer alternative to LinkedIn for high school students. Stobridge Education has engaged with over 1,000 participants through their nonprofit partner, Adeiur and has implemented its module curriculum in two universities and four student-serving organizations.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.